PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 70 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,609,617 | -46.1% | 336,308 | -10.7% | 0.02% | -42.3% |
| Q2 2023 | $10,398,184 | +46.9% | 376,473 | +22.4% | 0.03% | +30.0% |
| Q1 2023 | $7,077,100 | +31.9% | 307,700 | -37.5% | 0.02% | +17.6% |
| Q4 2022 | $5,367,338 | +159.2% | 491,965 | +100.2% | 0.02% | +142.9% |
| Q3 2022 | $2,071,000 | -17.1% | 245,705 | -22.2% | 0.01% | -12.5% |
| Q2 2022 | $2,497,000 | -63.5% | 315,644 | +9.4% | 0.01% | -60.0% |
| Q1 2022 | $6,832,000 | +610.9% | 288,518 | +926.8% | 0.02% | +900.0% |
| Q4 2021 | $961,000 | +120.4% | 28,100 | +14.2% | 0.00% | +100.0% |
| Q3 2021 | $436,000 | -86.8% | 24,600 | -66.5% | 0.00% | -85.7% |
| Q2 2021 | $3,293,000 | +52.2% | 73,377 | -12.1% | 0.01% | +16.7% |
| Q1 2021 | $2,163,000 | -31.4% | 83,516 | -46.6% | 0.01% | -33.3% |
| Q4 2020 | $3,152,000 | -26.8% | 156,366 | -29.0% | 0.01% | -40.0% |
| Q3 2020 | $4,305,000 | -15.9% | 220,203 | -24.1% | 0.02% | -40.0% |
| Q2 2020 | $5,121,000 | +561.6% | 289,978 | +164.5% | 0.02% | +316.7% |
| Q1 2020 | $774,000 | -46.1% | 109,623 | -46.2% | 0.01% | +50.0% |
| Q4 2019 | $1,437,000 | +141.9% | 203,884 | +312.5% | 0.00% | +100.0% |
| Q3 2019 | $594,000 | -59.8% | 49,421 | -59.5% | 0.00% | -60.0% |
| Q2 2019 | $1,479,000 | +156.3% | 122,124 | +166.2% | 0.01% | +150.0% |
| Q1 2019 | $577,000 | +49.9% | 45,877 | -19.8% | 0.00% | 0.0% |
| Q4 2018 | $385,000 | -74.1% | 57,178 | -60.4% | 0.00% | -50.0% |
| Q3 2018 | $1,487,000 | +24.6% | 144,519 | -18.6% | 0.00% | 0.0% |
| Q2 2018 | $1,193,000 | +323.0% | 177,479 | +441.1% | 0.00% | +300.0% |
| Q1 2018 | $282,000 | -76.5% | 32,800 | -43.2% | 0.00% | -75.0% |
| Q4 2017 | $1,202,000 | – | 57,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |